Northwire Canada EditionFriday, October 16, 2026
Northwire
⌕
GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8%

Healthcare

Page 44
  1. Mar 23, 2026 · 15:15 · AGN

    Algernon Health to open brain PET scanning clinic

    Algernon Health to open brain PET scanning clinic

    01
  2. Mar 23, 2026 · 12:49 · BLCO

    Bausch + Lomb releases Elios results

    Bausch + Lomb releases Elios results

    02
  3. Mar 23, 2026 · 08:24 · QNTM

    Quantum BioPharma Announces Peer-Reviewed Journal Publication of Groundbreaking Clinical Trial With Unbuzzd

    Quantum BioPharma Announces Peer-Reviewed Journal Publication of Groundbreaking Clinical Trial With Unbuzzd

    03
  4. Mar 23, 2026 · 07:30 · APS

    Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan of Arrangement

    Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan of Arrangement

    04
  5. Mar 23, 2026 · 07:01 · EYE

    Rise Nano Optics Announces FDA Class I Device Classification for SPECTRAGUARD(TM) Nano-Optic Lens Technology

    Rise Nano Optics Announces FDA Class I Device Classification for SPECTRAGUARD(TM) Nano-Optic Lens Technology

    05
  6. Mar 23, 2026 · 07:00 · AGN

    Algernon to Open the First Brain Dedicated PET Scanning Clinic in the U.S. at the HCA Florida University Medical Office Building

    Algernon to Open the First Brain Dedicated PET Scanning Clinic in the U.S. at the HCA Florida University Medical Office Building

    06
  7. Mar 23, 2026 · 04:00 · RKV

    Rakovina Therapeutics to Present New Data at the AACR Annual Meeting 2026 - World's Premier Cancer Research Forum

    Rakovina Therapeutics to Present New Data at the AACR Annual Meeting 2026 - World's Premier Cancer Research Forum

    07
  8. Mar 20, 2026 · 19:35 · QNTM

    Quantum Biopharma Announces Closing of Initial Tranche of Private Placement Offering

    Quantum Biopharma Announces Closing of Initial Tranche of Private Placement Offering

    08
  9. Mar 20, 2026 · 17:53 · DHT

    DRI Healthcare Trust closes $108.72M debenture offering

    DRI Healthcare Trust closes $108.72M debenture offering

    09
  10. Mar 20, 2026 · 16:59 · WELL

    Well Health supports Ontario primary care record system

    Well Health supports Ontario primary care record system

    10
  11. Mar 20, 2026 · 07:05 · ARCH

    Arch Biopartners Announces St. Michael's Hospital Commences Patient Dosing in the Phase II CS-AKI Trial of LSALT Peptide

    Arch Biopartners Announces St. Michael's Hospital Commences Patient Dosing in the Phase II CS-AKI Trial of LSALT Peptide

    11
  12. Mar 19, 2026 · 18:05 · MBIO

    Mindbio increases placement to $1.5-million

    Mindbio increases placement to $1.5-million

    12
  13. Mar 19, 2026 · 17:30 · RX

    BioSyent Releases Financial Results for Fourth Quarter and Full Year 2025

    BioSyent Releases Financial Results for Fourth Quarter and Full Year 2025

    13
  14. Mar 19, 2026 · 17:00 · APS

    Aptose Biosciences garners ISS nod for Hanmi deal

    Aptose Biosciences garners ISS nod for Hanmi deal

    14
← Newer Older →